Tag Archives: Blood Pressure – Hypertension
Hemodialysis.com Author Interview: Theresa I. Shireman, PhD, RPh
Director, MS-CR and TL1 Training Program
Department of Preventive Medicine & Public Health
Department of Health Policy & Management
University of Kansas School of Medicine
Hemodialysis.com: What are the main findings of the study?
Dr. Shireman: We found differential exposure over time to three classes of antihypertensives (ACE inhibitors/ARBs, beta-blockers, and calcium channel blockers) among chronic dialysis patients. Their exposure varied according to race/ethnicity, with African-Americans and Hispanics having lower levels of exposure over time as compared to Caucasians.